NEWRON PHARMACEUTICA

NWRN
Delayed Quote. Delayed  - 12/09 05:02:45 am
1.65CHF +2.48%

Turn to zoom
Prev.1.6100
Open1.6000
High1.6500
Low1.6000
Volume33 721
Latest news
7d ago
7d ago
7d ago
10/18
Chart NEWRON PHARMACEUTICALS S.P.A.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance1,822,102,06
Spread/Res.-9,3%-21%-20%
Spread/Supp.5,8%15%23%
Support1,561,431,34
Financials
Sales 2021 5,60 M 6,33 M 6,33 M
Net income 2021 -18,4 M -20,9 M -20,9 M
Net Debt 2021 11,5 M 13,0 M 13,0 M
P/E ratio 2021 -1,49x
Yield 2021 -
Capitalization 27,5 M 31,2 M 31,1 M
EV / Sales 2021 6,97x
EV / Sales 2022 10,4x
Nbr of Employees 23
Free-Float 95,0%
Company
Newron Pharmaceuticals SpA is an Italy-based clinical-stage biopharmaceutical company. It focuses on the discovery and development of pharmaceutical products. The Company is engaged in discovering and developing new therapies for diseases of the Central Nervous System (CNS) and pain. The Company...

>> Read more
Sector :
Biopharmaceuticals
Calendar :
2022-03-03 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 1,54 €
Average target price 4,58 €
Spread / Average Target 197%